Please login to the form below

Not currently logged in
Email:
Password:

Virginia Acha leaves Amgen for ABPI

Joins UK pharma trade body as director of research, medical and innovation

ABPI, Virginia AchaTrade body the Association of the British Pharmaceutical Industry (ABPI) has appointed Amgen director Virginia (Ginny) Acha as executive director in charge of research, medical and innovation.

Dr Acha is currently director of global regulatory and R&D policy across the EMEA region for Amgen, a role she has held for two years after joining the company from Pfizer.

She spent five years at Pfizer including periods as government affairs manager in the UK and director of international policy.

Dr Acha will take up her position at the ABPI in March at what will be a key time for the UK life sciences industry with the general election set to take place in May.

“These are exciting times in the science, development and delivery of medicines, and so it is a great privilege to be joining the ABPI now to help deliver our industry's views and aspirations for the future of healthcare,” she said.

In addition to her experience in the pharma industry Dr Acha has had an extensive career in academia holding posts at Imperial College London Business School, the Science Policy Research Unit (SPRU) at the University of Sussex and the Centre for Research in Innovation Management (CENTRIM) at the University of Brighton.

She is currently a visiting researcher in the innovation and entrepreneurship department at Imperial College Business School London.

27th January 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need...